« Back
Home /
CDC42BPA Antibody (N-term) Blocking Peptide

CDC42BPA Antibody (N-term) Blocking Peptide

Item no.	ABC-BP7120a
Manufacturer	Abcepta
Amount	500 ug
Category	Oncology By Cell Type Peptides & Proteins Peptides
Type	Peptides
Format	Lyophilized
Specific against	other
Citations	Dong, J.M., et al., Eur. J. Cell Biol. 81(4):231-242 (2002).Tan, I., et al., Mol. Cell. Biol. 21(8):2767-2778 (2001).Lam, L.T., et al., Hum. Mol. Genet. 9(14):2167-2173 (2000).Nakamura, N., et al., Genes Cells 5(7):571-581 (2000).Leung, T., et al., Mol. Cell. Biol. 18(1):130-140 (1998).
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	Serine/threonine-protein kinase MRCK alpha,CDC42-binding protein kinase alpha,DMPK-like alpha,Myotonic dystrophy kinase-related CDC42-binding kinase alpha,MRCK alpha,Myotonic dystrophy protein kinase-like alpha,CDC42BPA {ECO:0000312\|EMBL:CAH713361},KIAA0451
Similar products	KIAA0451, CDC42-binding protein kinase alpha, Serine/threonine-protein kinase MRCK alpha, MRCK alpha, DMPK-like alpha, Myotonic dystrophy kinase-related CDC42-binding kinase alpha, Myotonic dystrophy protein kinase-like alpha, CDC42BPA {ECO:0000312\|EMBL:CAH713361}
Available
Manufacturer - Category	Peptides; Blocking Peptides
Manufacturer - Targets	The synthetic peptide sequence used to generate the antibody AP7120a was selected from the N-term region of human CDC42BPA. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Bio Background	CDC42BPA is a member of the Serine/Threonine protein kinase family. This kinase contains multiple functional domains. Its kinase domain is highly similar to that of the myotonic dystrophy protein kinase (DMPK). This kinase also contains a Rac interactive binding (CRIB) domain, and has been shown to bind CDC42. It may function as a CDC42 downstream effector mediating CDC42 induced peripheral actin formation, and promoting cytoskeletal reorganization.
Gene Name	CDC42BPA {ECO:0000312\|EMBL:CAH71336.1}
Subtitle	Synthetic peptide
Formulation	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP7120a-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 11/6/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer